Prostate cancer is the most common form of cancer among men in England, with cases surging by 25 per cent between 2019 and 2023, according to NHS data. It’s also the second-deadliest form of the ...

The global statistics are terrifying. Prostate cancer is the fourth most common cancer in all populations, the second most common cancer among men worldwide, and ranks first in Europe, where a third ...

CAMBRIDGE, England--(BUSINESS WIRE)--Scientists in Cambridge have developed a new ‘super test’ for prostate cancer in an effort to revolutionise screening and diagnosis of the disease and accelerate ...

Prostate cancer tests in the UK will only be offered to men with a specific cancer gene variant in a controversial decision that will put pressure on the government to overrule the advice. Targeted ...

Testing the molecular profile of prostate tumours identifies which patients with advanced prostate cancer are more likely to benefit from a chemotherapy treatment called docetaxel and live longer, ...

Prostate Screening EpiSwitch (PSE) blood test shows significant potential as an accurate and rapid cancer screening diagnostic High accuracy (94%), PPV (92%), and NPV (94%) reported in the high-impact ...

Prostate cancer kills more than 12,000 men a year in the UK, slightly more than the number of women who die from breast cancer.

Prostate cancer screening should not be made routinely available for the vast majority of men in the UK, a committee advising the Government has said. In a draft recommendation, the UK National ...

AN ANNUAL free prostate cancer screening for men aged 40 and above has been proposed at the Cebu City Council to strengthen preventive healthcare and promote ea ...